Ritonavir and cobicistat as pharmacokinetic enhancers in pregnant women.

Authors:
Dr Ahizechukwu C Eke, MD, MPH, FWACS
Dr Ahizechukwu C Eke, MD, MPH, FWACS
Division of Maternal Fetal Medicine & Clinical Pharmacology, Johns Hopkins University School of Medicine, 600 N Wolfe Street
Maternal Fetal Medicine
Baltimore, Maryland | United States

Expert Opin Drug Metab Toxicol 2019 Jul 11;15(7):523-525. Epub 2019 Jun 11.

c Division of Neonatology, Department of Pediatrics , Boston University School of Medicine , Boston , MA , USA.

Download full-text PDF

Source
http://dx.doi.org/10.1080/17425255.2019.1628947DOI Listing
July 2019
13 Reads
2.831 Impact Factor

Publication Analysis

Top Keywords

pharmacokinetic enhancers
4
cobicistat pharmacokinetic
4
pregnant women
4
enhancers pregnant
4
ritonavir cobicistat
4
women
1
enhancers
1
pharmacokinetic
1
ritonavir
1
pregnant
1

References

(Supplied by CrossRef)

Renjifo B et al.
AIDS Rev 2015

Momper JD et al.
AIDS 2018

Similar Publications